Skip to content

Fulgent Genetics, Inc. FLGT Current maturities of long-term debt

Current maturities of long-term debt at other companies

Labcorp Holdings logo
Labcorp HoldingsLH
Personalis, Inc. logo
Personalis, Inc.PSNL
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
Opko Health logo
Opko HealthOPK

Other financials

Income statement

See full
Revenue$71.1M-3.2%
Gross profit$21.5M-24.2%
Operating income-$34.6M-74.9%
Net income-$24.8M-115%
EPS (diluted)-$0.80-116%

Balance sheet

See full
Cash & equivalents$23.4M-65.2%
Total debt$8.2M+40.5%
Total equity$1.0B-6.9%
Total assets$1.2B-4.1%

Cash flow

See full
Operating cash flow$7.1M+260%
CapEx$5.2M+10.3%
Free cash flow$1.9M+121%

Valuation

See full
Market cap$552.11M-7.1%
Enterprise value$536.92M+0.7%
P/S1.7×-0.3×

Profitability

See full
Gross margin38.7%-0.1pp
Operating margin-33.1%+17.4pp
Net margin-23%+43.3pp
FCF margin-36.9%

Returns & leverage

See full
Return on equity-6.8%+48.2pp
Debt / equity0.0×
Current ratio5.3×-1.0×

Where this comes from

Reported directly by Fulgent Genetics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:FinanceLeaseLiabilityCurrent.

The official record: Fulgent Genetics, Inc.’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Fulgent Genetics, Inc.'s current maturities of long-term debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Fulgent Genetics, Inc.'s current maturities of long-term debt?
Fulgent Genetics, Inc. (FLGT) reported current maturities of long-term debt of $271K in Q1 2026.
How has Fulgent Genetics, Inc.'s current maturities of long-term debt changed year-over-year?
Fulgent Genetics, Inc.'s current maturities of long-term debt decreased by 22.8% year-over-year, from $351K to $271K.
What is the long-term trend for Fulgent Genetics, Inc.'s current maturities of long-term debt?
Over 4 years (2021 to 2025), Fulgent Genetics, Inc.'s current maturities of long-term debt has grown at a 2.0% compound annual growth rate (CAGR), from $332K to $360K.